194 related articles for article (PubMed ID: 30562564)
1. Cytokine-targeted therapy for the management of solid organ transplant recipients.
Szczepanik A; Iasella CJ; McDyer JF; Ensor CR
Hum Immunol; 2019 Mar; 80(3):184-190. PubMed ID: 30562564
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression in solid organ-transplant recipients and impact on nutrition support.
Wilson NK; Kataria AD
Nutr Clin Pract; 2024 Feb; 39(1):109-116. PubMed ID: 38030572
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
5. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
Smedman TM; Line PD; Guren TK; Dueland S
Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
[No Abstract] [Full Text] [Related]
6. Immunosuppression in the pediatric transplant recipient.
Blondet NM; Healey PJ; Hsu E
Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
Front Immunol; 2018; 9():275. PubMed ID: 29515582
[TBL] [Abstract][Full Text] [Related]
8. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in transplant rejection.
Rath T
Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
[TBL] [Abstract][Full Text] [Related]
10. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.
Bush WW
AACN Clin Issues; 1999 May; 10(2):253-69; quiz 304-6. PubMed ID: 10578712
[TBL] [Abstract][Full Text] [Related]
11. Role of T cells in graft rejection and transplantation tolerance.
Issa F; Schiopu A; Wood KJ
Expert Rev Clin Immunol; 2010 Jan; 6(1):155-69. PubMed ID: 20383898
[TBL] [Abstract][Full Text] [Related]
12. [Modern immunosuppression after solid organ transplantation].
Beimler J; Morath C; Zeier M
Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922
[TBL] [Abstract][Full Text] [Related]
13. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.
Ulsh PJ; Yang HC; Holman MJ; Ahsan N
J Transpl Coord; 1999 Jun; 9(2):114-8. PubMed ID: 10703393
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
[TBL] [Abstract][Full Text] [Related]
15. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.
Merino D; San Segundo D; Medina JM; Rodrigo E; Asensio E; Irure J; Fernández-Fresnedo G; Arias MA; López-Hoyos M
Immunology; 2016 Jun; 148(2):206-15. PubMed ID: 26931075
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant diabetes mellitus. The role of immunosuppression.
Jindal RM; Sidner RA; Milgrom ML
Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitors in Organ Transplant Patients.
Kittai AS; Oldham H; Cetnar J; Taylor M
J Immunother; 2017 Sep; 40(7):277-281. PubMed ID: 28719552
[TBL] [Abstract][Full Text] [Related]
20. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance.
Wadia PP; Tambur AR
Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
